McAdam »

Axsome Therapeutics shares owned by McAdam

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by McAdam from 13F filings

Historical chart of McAdam investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by McAdam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by McAdam

Quarter filed Position value Share count Share price at filing
2025-09-30 $267k 2.2k 121.45
2025-06-30 $229k 2.2k 104.39
2025-03-31 $256k 2.2k 116.63
2019-12-31 $219k 2.1k 103.60
2018-09-30 $7.0k 2.0k 3.50
2018-06-30 $6.0k 2.0k 3.00

More positions owned by McAdam

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Spdr Series Trust Portfolio Ln Tsr (SPTL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Sml Cp Grw Etf (VBK)

View all positions for McAdam

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Rtw Investments
Macquarie Group
Geode Capital Management
Invesco
State Street Corporation
FMR
Deep Track Capital
Fairmount Funds Management
Eventide Asset Management
Alethea Capital Management
Susquehanna International
OrbiMed Advisors

View all funds holding Axsome Therapeutics